SPDR S&P Biotech ETF $XBI Stock Position Lowered by Madrona Financial Services LLC

Madrona Financial Services LLC lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.3% during the third quarter, Holdings Channel reports. The firm owned 131,913 shares of the exchange traded fund’s stock after selling 4,542 shares during the quarter. SPDR S&P Biotech ETF makes up about 3.2% of Madrona Financial Services LLC’s portfolio, making the stock its 8th largest holding. Madrona Financial Services LLC’s holdings in SPDR S&P Biotech ETF were worth $20,800,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in XBI. Sowell Financial Services LLC grew its stake in SPDR S&P Biotech ETF by 1.7% during the 3rd quarter. Sowell Financial Services LLC now owns 8,058 shares of the exchange traded fund’s stock worth $1,271,000 after buying an additional 134 shares during the last quarter. Canton Hathaway LLC increased its position in SPDR S&P Biotech ETF by 12.5% during the third quarter. Canton Hathaway LLC now owns 7,475 shares of the exchange traded fund’s stock worth $1,179,000 after buying an additional 830 shares during the period. Andrew Hill Investment Advisors Inc. purchased a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $813,000. Compass Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $80,000. Finally, Root Financial Partners LLC purchased a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $31,000.

SPDR S&P Biotech ETF Trading Down 1.4%

XBI stock opened at $149.54 on Friday. The company has a market capitalization of $10.17 billion, a P/E ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a twelve month low of $106.30 and a twelve month high of $169.89. The business has a 50 day simple moving average of $157.40 and a 200-day simple moving average of $147.73.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.